A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects
Clinical trial NCT01718145 · COMPLETED
Trial details
- NCT number
- NCT01718145
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-12-01
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.